Celltrion chairman\
Scope
Date
~
-
Shareholder activism
ISS supports Shinhan Financial Group chairman nominee
Proxy adviser Institutional Shareholder Services Inc. (ISS) is supporting the appointment of Shinhan Financial Group chairman nominee Jin Ok-Dong as...
Mar 10, 2023 (Gmt+09:00)
-
Corporate governance
SK Group affiliates hire more female outside directors
Major affiliates of South Korea’s SK Group are recruiting a large number of female outside directors with the arrival of the season of regular...
Mar 10, 2023 (Gmt+09:00)
-
Fraud scandals
Hankook Tire chairman arrested for alleged embezzlement
The head of Hankook Tire & Technology Co., South Korea’s top tire maker, was arrested on Thursday on charges of embezzlement, breach of tr...
Mar 09, 2023 (Gmt+09:00)
-
Food & Beverage
Korea’s SPC Samlip, Siam Makro to tie up for Thai bakery business
SPC Samlip Corp., a unit of South Korea’s food and bakery giant SPC Group, said on Monday it has forged a business partnership with Siam Makro...
Mar 06, 2023 (Gmt+09:00)
-
Food & Beverage
Lotte Chairman to return to beverage unit's boardroom
Lotte Group Chairman Shin Dong-bin is slated to return as an inside director of Lotte Chilsung Beverage Co., the group’s subsidiary and one of...
Mar 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion ex-Chairman Seo set to return to management; group stocks rally
South Korea’s biosimilar giant Celltrion Group’s founder and Honorary Chairman Seo Jung-jin is readying to return to management just two...
Mar 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion teams up with bio venture to develop new anti-cancer drug
South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...
Feb 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Brazil approves Celltrion Pharm’s syringe facility
Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Truxima shows safety, efficacy in post-marketing study
South Korean biopharmaceutical company Celltrion Inc. reported on Wednesday that its biosimilar drug Truxima (rituximab), a generic version of Roche...
Feb 16, 2023 (Gmt+09:00)
-
Korean chipmakers
SK Hynix may not slash chipmaking investment in 2023: vice chairman
SK Hynix Inc., the world’s second-largest memory chipmaker, will not significantly cut its semiconductor output this year, Vice Chairman Park ...
Feb 15, 2023 (Gmt+09:00)
-
Leadership & Management
Plain sailing for LS with record earnings under Chairman Koo’s leadership
LS Group’s plan to groom new growth engines from batteries to electric vehicles and semiconductors is set to gain impetus after South Korea&rs...
Feb 15, 2023 (Gmt+09:00)
-
Robotics
Samsung Electronics, KAIST join forces to train robotics experts
Samsung Electronics Co. has partnered with the Korea Advanced Institute of Science and Technology (KAIST) to cultivate specialists in robotics. On M...
Feb 14, 2023 (Gmt+09:00)
-
Shareholder activism
Korea’s Hyundai Dept. Store drops holding company plan
South Korea’s major retailer Hyundai Department Store Group Co. gave up a plan to split off its core high-end shopping mall affiliate and conv...
Feb 10, 2023 (Gmt+09:00)
-
Banking & Finance
KB Financial Group holds investment conference via metaverse
South Korea's KB Financial Group on Tuesday presented its investment philosophy to individual and institutional customers in the metaverse, a three-...
Feb 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches anti-cancer biosimilar Vegzelma in Japan
Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion increases its stake in British ADC developer Iksuda
Celltrion Inc. has secured an additional stake in the UK's antibody-drug conjugate (ADC) developer Iksuda Therapeutics.According to Celltrion on Wed...
Jan 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for EMA approval of smaller dose formulation of Yuflyma
Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...
Jan 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare lands biosimilar deal in Brazil for 2nd straight year
South Korea's Celltrion Healthcare Co. on Tuesday said that for the second straight year, it landed an order for infliximab, an antibody used to tre...
Jan 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion develops oral antibody drug with US bio company
South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion acquires approval to sell Vegzelma in Canada
South Korea's biosimilar heavyweight Celltrion Inc. has obtained permission from the Canadian health ministry to sell anticancer biosimilar Vegzelma...
Jan 05, 2023 (Gmt+09:00)
-
Corporate strategy
Hyundai is not a carmaker but a tech firm: Chairman Chung
Hyundai Motor Group Chairman Chung Euisun has vowed to turn the South Korean automotive giant into a state-of-the-art tech company to lead the pack ...
Jan 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Remsima receives approval in 100 countries in 10 years
South Korea's most valuable biopharmaceutical company Celltrion Inc. said on Tuesday that its antibody biosimilar Remsima (ingredient: infliximab) h...
Jan 03, 2023 (Gmt+09:00)
-
ESG
Woori Financial wins MSCI ESG global leader rating for 2nd year
Woori Financial Group said on Thursday it has earned an AA rating for the second consecutive year in the global ESG rating announced by Morgan Stanl...
Dec 30, 2022 (Gmt+09:00)
-
Bio & Pharma
KOICA donates Celltrion's Herzuma to Ukraine
Celltrion Healthcare Co. said on Monday that Herzuma (ingredient name: Trastuzumab) was dispatched to patients in Ukraine by the Korea International...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
Samsung Chairman Jay Y. Lee flies to Vietnam for global business
Samsung Electronics Co. Chairman Jay Y. Lee embarked on a business trip to Vietnam on Wednesday to attend an opening ceremony for a research and dev...
Dec 21, 2022 (Gmt+09:00)
-
Samsung Group
Samsung suspends staff overseas training to cut costs
Samsung Group canceled overseas training for South Korean staff for the first time in 32 years as the country’s top conglomerate tried to cut ...
Dec 14, 2022 (Gmt+09:00)
-
Samsung Group
Samsung’s Lee visits UAE nuclear plant project on first trip as chairman
Samsung Group leader Jay Y. Lee is in Abu Dhabi to meet with businesspeople and politicians and tour the Barakah nuclear power plant project in the ...
Dec 07, 2022 (Gmt+09:00)
-
Executive reshuffles
Samsung Elec names first female president under Chairman Jay Y. Lee
Samsung Electronics Co., the world’s largest memory chip and smartphone maker, has carried out its year-end executive reshuffle, marked by its...
Dec 05, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion to seek FDA approval for sale of Remsima SC by year-end
Celltrion Inc. said it has confirmed the effectiveness and safety of Remsima SC in its third-phase global clinical trials, conducted on 438 patients...
Nov 28, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand